We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Anticonvulsant drug level testing is available for the following:

  • Perampanel (Fycompa)
  • Oxcarbazepine (Trileptal) (including the 10-OH-Carbazepine active metabolite)
  • Pregabalin (Lyrica)
  • Levetiracetam (Keppra)
  • Lamotrigine (Lamictal)
  • Gabapentin (Neurontin)
  • Topiramate (Topamax)
  • Carbamazepine with Carbamazepine-epoxide (major active metabolite)
  • Phenytoin
  • Valproate
  • Lacosamide

Anticonvulsant Therapeutic Drug Monitoring